Does renal perfusion pressure, vascular tone, and ACE genetic variation influence eGFR?

The regulation of estimated glomerular filtration rate (eGFR) relies on a precise interplay between systemic hemodynamics, intrinsic vascular control, and genetic factors governing vasoactive pathways.

Renal hemodynamics and vascular tone

• Autoregulatory capacity: The kidney maintains a stable GFR across a broad physiological mean arterial pressure range of approximately 75–180 mmHg. Within this range, pressure-dependent autoregulation buffers filtration; outside these limits, GFR becomes highly pressure-dependent.
• Arteriolar resistance: Glomerular capillary hydrostatic pressure is directly dictated by the vascular tone of preglomerular (afferent) and postglomerular (efferent) arterioles. Afferent vasoconstriction reduces filtration pressure, while efferent tone has a biphasic effect: moderate constriction elevates GFR, whereas severe constriction limits plasma flow and lowers GFR.

Genetic and molecular mechanisms

• Myogenic autoregulation: Fluctuations in renal perfusion pressure stretch the afferent arteriole, initiating a myogenic response that alters vascular smooth muscle tone to stabilize filtration.
• ACE polymorphisms: Genetic variations in the angiotensin-converting enzyme (ACE) pathway, primarily the insertion/deletion (I/D) polymorphism (rs1799752) and its proxy rs4343, alter local tissue ACE activity and dictate vascular resistance.
• Vascular reactivity: Individuals homozygous for the deletion allele (DD genotype) or the rs4343-G variant express higher systemic and intrarenal ACE activity. This accelerates the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, leading to elevated renal vascular resistance and decreased renal plasma flow, particularly during metabolic stress or high sodium intake.

Bottom line

• Renal perfusion pressure and arteriolar tone are fundamental determinants of eGFR, regulated via intrinsic myogenic feedback and dynamically modulated by ACE pathway polymorphisms (such as the DD genotype) that enhance local vasoconstrictive sensitivity.